Rosiglitazone
id:
rosiglitazone-171-5660168
title:
Rosiglitazone
text:
Rosiglitazone is an antidiabetic drug in the thiazolidinedione class. It works as an insulin sensitizer, by binding to the PPAR in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug or for use in combination with metformin or with glimepiride. First released in 1999, annual sales peaked at approximately $2.5-billion in 2006; however, following a meta-analysis in 2007 that linked the drug's use to an
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Rosiglitazone
date created:
2004-04-18T13:51:20Z
date modified:
2024-09-01T05:38:57Z
main entity:
{"identifier":"Q424771","url":"https://www.wikidata.org/entity/Q424771"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/0e/Rosiglitazone_ball-and-stick.png","width":1999,"height":1319}
fields total:
13
integrity:
16